Cargando…
Lysophosphatidic Acid Enhances Stromal Cell-Directed Angiogenesis
Ischemic diseases such as peripheral vascular disease (PVD) affect more than 15% of the general population and in severe cases result in ulcers, necrosis, and limb loss. While the therapeutic delivery of growth factors to promote angiogenesis has been widely investigated, large-scale implementation...
Autores principales: | Binder, Bernard Y. K., Sondergaard, Claus S., Nolta, Jan A., Leach, J. Kent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846884/ https://www.ncbi.nlm.nih.gov/pubmed/24312635 http://dx.doi.org/10.1371/journal.pone.0082134 |
Ejemplares similares
-
Promising Pharmacological Directions in the World of Lysophosphatidic Acid Signaling
por: Stoddard, Nicole C., et al.
Publicado: (2015) -
Lysophosphatidic acid enhances breast cancer cells-mediated osteoclastogenesis
por: Nam, Ju-Suk, et al.
Publicado: (2018) -
Targeting Lysophosphatidic Acid Signaling Retards Culture-Associated Senescence of Human Marrow Stromal Cells
por: Kanehira, Masahiko, et al.
Publicado: (2012) -
2-Carba-lysophosphatidic acid is a novel β-lysophosphatidic acid analogue with high potential for lysophosphatidic acid receptor activation and autotaxin inhibition
por: Fukasawa, Keiko, et al.
Publicado: (2021) -
Elevated plasma levels of lysophosphatidic acid and aberrant expression of lysophosphatidic acid receptors in adenomyosis
por: Yang, Bicheng, et al.
Publicado: (2017)